What: The removal of thousands of CDC pages has complicated access to comprehensive birth control guidelines essential for clinical care.
Key line: “Dr. Jessica Weyer… could not guide her patients’ choice…”
Source: New York Times.
What: The removal of thousands of CDC pages has complicated access to comprehensive birth control guidelines essential for clinical care.
Key line: “Dr. Jessica Weyer… could not guide her patients’ choice…”
Source: New York Times.
Systemic hormones may worsen incontinence; local therapy helps, study says.
WHI funding restored after backlash; $140 saved for every dollar spent, researchers say.
The Guardian reviews how “fetal personhood” laws could criminalize abortion patients.
New data shows women face more complications after heart procedures.
NPR adds more detail to WHI’s shutdown and the loss of 1990s-era women’s health data.
Meta-analysis finds prenatal cannabis use raises risks of preterm and low birth weight.
An editorial calls for moving beyond reproductive-only focus in women’s health.
Trump administration floats baby bonuses, fertility funding, and fertility-focused Fulbrights.
WBUR spotlights MAP volunteers mailing abortion meds to banned states.
State attempts to expand fertility coverage face opposition from cost and fetal personhood movements.
WHI funding restored after backlash; $140 saved for every dollar spent, researchers say.
Trump administration floats baby bonuses, fertility funding, and fertility-focused Fulbrights.
Right-leaning outlet calls out bad data used to attack abortion pills.
New research finds minor, temporary changes in menstrual cycle length post-vaccine.
Right-leaning outlet calls out bad data used to attack abortion pills.
Even with dye bans, ultra-processed food remains the real issue, The Atlantic argues.
Study finds no mass OBGYN flight from states with abortion bans—yet.
Study: Swedish moms with higher-paid parental leave had better mental health postpartum.
Makary says he won’t act on mifepristone for now, but is “awaiting more data.”
DOJ says states can’t overrule FDA—even as future restrictions loom.